SK
Sunil Kumar Sundrani
About Sunil Kumar Sundrani
Sunil Kumar Sundrani has 1 years in corporate governance. Formerly with 7 companies, such as Nirvana Work Force Private Limited and Tradegen Ventures Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Nirvana Work Force Private Limited
U78300MP2024PTC073150
|
Additional Director | 27 Nov 2024 | 2024 | Active |
|
Tradegen Ventures Private Limited
U47190MP2025PTC077343
|
Director | 17 Jun 2025 | 2025 | Active |
|
Sars Medicaments Private Limited
U46497KA2025PTC198417
|
Director | 21 Feb 2025 | 2025 | Active |
|
Nexco Ventures Private Limited
U47190MP2025PTC076132
|
Director | 15 Apr 2025 | 2025 | Active |
|
Blulime Consultancy Llp
ABB-4065
|
Designated Partner | 08 Feb 2025 | 2022 | Active |
|
Devritti Yoga And Wellness Private Limited
U93190MP2022PTC059359
|
Additional Director | 21 Dec 2024 | 2022 | Active |
|
Webnomysis Private Limited
U72900MP2022PTC062697
|
Additional Director | 05 Feb 2025 | 2022 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunil Kumar Sundrani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunil Kumar Sundrani
Sunil Kumar Sundrani has 1 years in corporate governance. Formerly with 7 companies, such as Nirvana Work Force Private Limited and Tradegen Ventures Private Limited. Engaged in General Business. Contributes to corporate operations.
Sunil Kumar Sundrani is associated with 0 companies as a director.
Sunil Kumar Sundrani has expertise in General Business.
Sunil Kumar Sundrani has 1 years in corporate governance.